Main Article Content
Toxoplasma gondii is a parasite capable of infecting humans and other warm-blooded animals, that it is estimated to have chronically infected a third of the world population. While mostly asymptomatic in immunocompetent patients, it is considered a serious disease in immunocompromised patients, with potentially fatal consequences. The current treatment method used can trigger numerous negative side effects. The aim of this review is to evaluate current studies available regarding potential new candidates to be used against Toxoplasma gondii.
This work is licensed under a Creative Commons Attribution 4.0 International License.